Company page

Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. is a public company traded under the ticker PRAX in the American market. The company has a market capitalization of approximately $8.77 billion. Praxis focuses on developing innovative treatments for neurological diseases, aiming to address significant unmet medical needs.